Marker Therapeutics (MRKR) Beginning Cash Balance (2012 - 2014)

Marker Therapeutics (MRKR) has 3 years of Beginning Cash Balance data on file, last reported at $48589.0 in Q1 2014.

• Beginning Cash Balance for Q1 2014 came in at $48589.0, up 43.59% year-over-year; the trailing twelve-month figure through Dec 2017 was $48589.0 (down 41.05% YoY), and the FY2016 annual result was $23000.0, changed N/A from the prior year.
• Beginning Cash Balance climbed to $48589.0 in Q1 2014 per MRKR's latest filing, from $33839.0 in the prior quarter.
• Over five years, Beginning Cash Balance peaked at $250234.0 in Q1 2012 and troughed at $33839.0 in Q1 2013.
• A 3-year average of $110887.3 and a median of $48589.0 in 2014 frame the typical range for Beginning Cash Balance.
• The sharpest annual moves came in 2013 and 2014: Beginning Cash Balance plunged 86.48% in 2013, then jumped 43.59% in 2014.
• A 3-year view of Beginning Cash Balance shows it stood at $250234.0 in 2012, then sank by 86.48% to $33839.0 in 2013, then jumped by 43.59% to $48589.0 in 2014.
• Business Quant data shows MRKR's Beginning Cash Balance at $48589.0 in Q1 2014, $33839.0 in Q1 2013, and $250234.0 in Q1 2012.